Corey Ohnmacht
Director of Bioanalytical and Quality Control Services at ICON
False
Advertisement
What’s Evaluated in a Stability Study?
August 15, 2025
Looking at the importance of stability programs in early clinical drug product development.
4 min read
Newsletters
Receive the latest pharmaceutical news, personalities, education, and career development – weekly to your inbox.
